Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Mesothelin-Targeted CAR T-Cell Therapy Shows Early Efficacy in Advanced Solid Cancers

April 4, 2019 By Law Offices of Thomas J. Lamb, P.A.

… Malignant pleural mesothelioma is an aggressive solid tumor that arises either as a primary tumor or as metastatic disease secondary to lung or breast cancer. The disease has a poor prognosis, and the FDA has not approved a new treatment for malignant pleural mesothelioma since 2003, Adusumilli noted.

The disease responds poorly to immune checkpoint inhibition, which is associated with a median progression-free survival (PFS) of 4 to 5.6 months. The National Comprehensive Cancer Network included anti–PD-1 therapy as an option for second-line treatment of malignant pleural mesothelioma.

Adusumilli and colleagues previously demonstrated that mesothelin, a cell-surface antigen, is highly expressed in malignant pleural disease and is associated with an aggressive clinical course and poor survival. Normal tissues have only low-level expression of mesothelin.

Investigators developed fully human mesothelin-targeted CARs, incorporating the inducible caspase-9 safety switch that can be activated to neutralize CAR T cells in the event of unexpected toxicity. In preclinical studies, intrapleural administration of the CAR T cells demonstrated antitumor activity. The studies also showed that CAR T cells can become functionally exhausted in the presence of a large tumor burden, but administration of an anti–PD-1 agent can revive CAR T-cell function. [footnotes omitted] [Read article in full at original source]


Mesothelioma, Asbestos, and Legal Compensation: Basic Facts

Asbestos-Mesothelioma Case Evaluation Form
Free.  Confidential.  No Obligation.

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.